HIGHLIGHTS
- who: Bryan Gervais de Liyis from the (UNIVERSITY) have published the paper: A review of literature on Compound 21-loaded gelatin nanoparticle: a promising nose-to-brain therapy for multi-infarct dementia, in the Journal: (JOURNAL)
- what: The aim of this review is to identify the potential of Compound 21 (C21) gelatin nanoparticle through the nose-to-brain route as therapy for MID.
SUMMARY
The multitude of neurological disorders with considerable cognitive deterioration in one or more cognitive domains (executive, memory, language, and visuospatial) falls under the general term major neurocognitive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.